Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AUPH

Aurinia Pharmaceuticals Inc

17.23

Jun 26 • 04:00PM ET -0.32 (-1.82%)

Healthcare Biotechnology Canada Mid NASD

Peers: MIRM PTCT RYTM VKTX BMRN INCY KRYS AXSM NBIX PHVS

| Held by: IWM IWO IBB JSMD VTWO FESM VHT AVSC JSML SPDW

Scroll to Statements

Index	RUT	P/E	7.96	EPS (ttm)	2.16	Insider Own	12.11%	Shs Outstand	130.77M	Perf Week	4.68%
Market Cap	2.22B	Forward P/E	13.94	EPS next Y	1.24	Insider Trans	12.37%	Shs Float	113.03M	Perf Month	10.88%
Enterprise Value	1.91B	PEG	-	EPS next Q	0.24	Inst Own	61.71%	Short Float	8.19%	Perf Quarter	18.01%
Income	298.21M	P/S	7.43	EPS this Y	-53.62%	Inst Trans	1.47%	Short Ratio	7.11	Perf Half Y	6.29%
Sales	298.30M	P/B	3.97	EPS next Y	28.75%	ROA	48.54%	Short Interest	9.25M	Perf YTD	8.03%
Book/sh	4.34	P/C	5.85	EPS next 5Y	-4.55%	ROE	64.98%	52W High	19.25 -10.49%	Perf Year	99.65%
Cash/sh	2.95	P/FCF	13.27	EPS past 3/5Y	- -	ROIC	48.24%	52W Low	7.28 136.51%	Perf 3Y	88.72%
Dividend Est.	-	EV/EBITDA	12.76	Sales past 3/5Y	28.30% 41.38%	Gross Margin	89.74%	Volatility	6.74% 3.99%	Perf 5Y	20.49%
Dividend TTM	-	EV/Sales	6.39	EPS Y/Y TTM	696.05%	Oper. Margin	43.58%	ATR (14)	0.77	Perf 10Y	562.67%
Dividend Ex-Date	-	Quick Ratio	5.01	Sales Y/Y TTM	20.62%	Profit Margin	99.97%	RSI (14)	58.52	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	5.55	EPS Q/Q	53.13%	SMA20	5.61%	Beta	1.38	Target Price	17.00
Payout	0.00%	Debt/Eq	0.12	Sales Q/Q	24.40%	SMA50	7.95%	Rel Volume	3.22	Prev Close	17.55
Employees	128	LT Debt/Eq	0.09	Earnings	May 07 BMO	SMA200	17.06%	Avg Volume	1.30M	Price	17.23
IPO	Oct 20, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	28.21% 0.94%	Trades		Volume	4,185,420	Change	-1.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)